NE Davidson

3.1k total citations
15 papers, 787 citations indexed

About

NE Davidson is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, NE Davidson has authored 15 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 11 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in NE Davidson's work include Breast Cancer Treatment Studies (6 papers), Cancer Genomics and Diagnostics (6 papers) and Advanced Breast Cancer Therapies (4 papers). NE Davidson is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Cancer Genomics and Diagnostics (6 papers) and Advanced Breast Cancer Therapies (4 papers). NE Davidson collaborates with scholars based in United States, Japan and Switzerland. NE Davidson's co-authors include H M Lazarus, BW Cooper, MS Tallman, MJ Kennedy, TJ Moss, Moss Tj, N.J. Bundred, Gϋnter von Minckwitz, Rebecca DeBoer and J. Miller and has published in prestigious journals such as Blood and Cancer Research.

In The Last Decade

NE Davidson

15 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
NE Davidson United States 6 542 275 237 169 96 15 787
BW Cooper United States 5 500 0.9× 253 0.9× 275 1.2× 161 1.0× 87 0.9× 9 763
TJ Moss United States 6 377 0.7× 198 0.7× 236 1.0× 128 0.8× 68 0.7× 8 594
KJ Bross Germany 7 406 0.7× 140 0.5× 432 1.8× 146 0.9× 72 0.8× 7 870
Rachel Koldej Australia 17 247 0.5× 99 0.4× 158 0.7× 293 1.7× 83 0.9× 59 771
Moss Tj United States 8 290 0.5× 211 0.8× 201 0.8× 190 1.1× 58 0.6× 12 624
Maria DeSantis Austria 8 244 0.5× 78 0.3× 206 0.9× 283 1.7× 82 0.9× 11 659
Wilma G. M. Kroes Netherlands 18 366 0.7× 136 0.5× 122 0.5× 395 2.3× 84 0.9× 39 1.0k
Cecilia Carpio Spain 15 388 0.7× 79 0.3× 110 0.5× 214 1.3× 47 0.5× 55 774
Sheila Sait United States 16 229 0.4× 160 0.6× 124 0.5× 313 1.9× 177 1.8× 38 764
Markus Kremer Germany 16 273 0.5× 187 0.7× 99 0.4× 257 1.5× 114 1.2× 22 739

Countries citing papers authored by NE Davidson

Since Specialization
Citations

This map shows the geographic impact of NE Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by NE Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites NE Davidson more than expected).

Fields of papers citing papers by NE Davidson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by NE Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by NE Davidson. The network helps show where NE Davidson may publish in the future.

Co-authorship network of co-authors of NE Davidson

This figure shows the co-authorship network connecting the top 25 collaborators of NE Davidson. A scholar is included among the top collaborators of NE Davidson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with NE Davidson. NE Davidson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tasdemir, Nilgun, Lei Zhu, Janet H. Scott, et al.. (2019). Abstract PD7-03: Investigating cortactin as a genetic driver of disease progression in invasive lobular carcinoma. Cancer Research. 79(4_Supplement). PD7–3. 1 indexed citations
2.
3.
Butler, Lisa, Rachelle W. Johnson, Emilia J. Diego, et al.. (2016). Abstract P3-05-14: A neoadjuvant window trial of endocrine response in women with invasive lobular carcinoma. Cancer Research. 76(4_Supplement). P3–5. 1 indexed citations
4.
Adams, Sylvia, Sandra Demaria, LJ Goldstein, et al.. (2013). Abstract S1-07: Prognostic value of tumor-infiltrating lymphocytes (TILs) in two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. Cancer Research. 73(24_Supplement). S1–7. 13 indexed citations
5.
Lin, Yan, et al.. (2013). Abstract P2-11-10: Intra-tumor heterogeneity affects multi-gene test prognostic risk stratification. Cancer Research. 73(24_Supplement). P2–11. 1 indexed citations
6.
Rimm, David L., Heather H. Cheng, Maria Vassilakopoulou, et al.. (2012). Abstract S5-4: EGFR expression measured by quantitative immunofluorescense is associated with decreased benefit from trastuzumab in the adjuvant setting in the NCCTG (Alliance) N9831 trial.. Cancer Research. 72(24_Supplement). S5–4. 7 indexed citations
7.
Moreno‐Aspitia, Alvaro, et al.. (2011). P2-12-02: Correlation between BMI and Clinical Outcome of Patients with Early Stage HER2+ Breast Cancer from the N9831 Clinical Trial.. Cancer Research. 71(24_Supplement). P2–12. 2 indexed citations
8.
Andreopoulou, Eleni, Jane Zorzi, Igor Espinoza‐Delgado, et al.. (2011). OT3-01-06: A Phase 2 Study Investigating the Safety, Efficacy and Surrogate Biomarkers of Response of 5-Azacitidine (5-AZA) and Entinostat (MS-275) in Patients with Advanced Breast Cancer.. Cancer Research. 71(24_Supplement). OT3–1. 6 indexed citations
9.
10.
Gray, Robert P., LJ Goldstein, BH Childs, et al.. (2009). GRB7-dependent pathways are potential therapeutic targets in triple-negative breast cancer.. Cancer Research. 69(2_Supplement). 25–25. 3 indexed citations
11.
Davidson, NE, et al.. (2009). c-MYC amplification and correlation with patient outcome in early stage HER2+ breast cancer from the NCCTG adjuvant intergroup trial N9831.. Cancer Research. 69(2_Supplement). 56–56. 4 indexed citations
12.
Rugo, HS, LA Carey, Erica L. Mayer, et al.. (2009). Assays of circulating tumor cells and outcome in the triple-negative breast cancer trial TBCRC001.. Cancer Research. 69(2_Supplement). 6048–6048. 1 indexed citations
13.
Eidtmann, Holger, N.J. Bundred, Rebecca DeBoer, et al.. (2009). The effect of zoledronic acid on aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36 months follow-up of ZO-FAST.. Cancer Research. 69(2_Supplement). 44–44. 48 indexed citations
14.
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by BW Cooper Breakdown of academic impact, for papers by TJ Moss Breakdown of academic impact, for papers by KJ Bross Breakdown of academic impact, for papers by Rachel Koldej Breakdown of academic impact, for papers by Moss Tj Breakdown of academic impact, for papers by Maria DeSantis Breakdown of academic impact, for papers by Wilma G. M. Kroes Breakdown of academic impact, for papers by Cecilia Carpio Breakdown of academic impact, for papers by Sheila Sait Breakdown of academic impact, for papers by Markus Kremer
Rankless by CCL
2026